×
Hero Background

CAR T Cell Therapy Companies

ID: MRFR/HC/6630-CR
200 Pages
Rahul Gotadki
July 2025

CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is an innovative approach in cancer treatment, where a patient's T-cells are genetically engineered to target and destroy cancer cells. Several companies are at the forefront of CAR-T cell therapy development and commercialization.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

CAR T Cell Therapy Market Research Report - Global Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the CAR T Cell Therapy Market


CAR-T Cell Therapy Key Companies*Disclaimer: List of key companies in no particular orderLatest CAR-T cell therapy Companies Update

  • Bluebird Bio (US)

  • Intellia Therapeutics (US)

  • Noile-Immune Biotech (Japan)

  • Celgene Corporation (US)

  • Bellicum Pharmaceuticals, Inc. (US)

  • Novartis International AG (Swiss)

  • Celyad (Belgium)

  • Cellectis (France)

  • Servier Laboratories (France)

  • Pfizer Inc. (US)

  • Caribou Biosciences, Inc. (US)

  • Mereck KGaA (Germany)

  • Amgen Inc. (US)